Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.950
+0.020 (0.51%)
Aug 7, 2025, 4:00 PM - Market closed

The Aaron's Company Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for The Aaron's Company.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for The Aaron's Company.

Recommendation Trends

RatingDec '21Jan '22Feb '22Mar '22Apr '22May '22
Strong Buy111110
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111110

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aMay 26, 2022
Maxim Group
Maxim Group
Strong Buy
Upgrades
$220
Strong BuyUpgrades$220+5,469.62%Feb 18, 2021
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 17, 2020
Maxim Group
Maxim Group
Strong Buy
Upgrades
$600
Strong BuyUpgrades$600+15,089.87%Oct 23, 2019
Roth Capital
Roth Capital
Hold
Downgrades
n/a
HoldDowngradesn/an/aNov 10, 2017
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
from -5.23
EPS Next Year
n/a
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Revenue
4.84M1.53M557.00K184.00K-
Revenue Growth
85.72%-68.46%-63.50%-66.97%-
EPS
-96.70-18.04-15.19-7.41-5.23
EPS Growth
-----
Forward PE
-----
No. Analysts
-----
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.